title: Regulation of diurnal variation of cholesterol 7alpha-hydroxylase (CYP7A1) activity in healthy subjects.
abstract: Cholesterol 7alpha-hydroxylase (CYP7A1), the key regulatory enzyme of bile acid synthesis, displays a pronounced diurnal variation. To better understand the regulation of CYP7A1 activity, three day-long examinations were carried out in 12 healthy men. The concentrations of 7alpha-hydroxycholest-4-en-3-one (C4), a surrogate marker of CYP7A1 activity, bile acids (BA), insulin, glucose, nonesterified fatty acids, triglycerides, and cholesterol were measured in serum in 90-min intervals from 7 AM till 10 PM. To lower and to increase BA concentration during the study, the subjects received cholestyramine and chenodeoxycholic acid (CDCA), respectively, in two examinations. No drug was used in the control examination. There was a pronounced diurnal variation of C4 concentration with a peak around 1 PM in most of the subjects. The area under the curve (AUC) of C4 concentration was five times higher and three times lower when subjects were treated with cholestyramine and CDCA, respectively. No relationship was found between AUC of C4 and AUC of BA concentration, but AUC of C4 correlated positively with that of insulin. Moreover, short-term treatment with cholestyramine resulted in about 10 % suppression of glycemia throughout the day. Our results suggest that insulin is involved in the regulation of diurnal variation of CYP7A1 activity in humans.
authors.affiliation: Institute for Clinical and Experimental Medicine, Prague, Czech Republic. jan.kovar@medicon.cz
authors.forename: J
authors.initials: J
authors.lastname: Kovář
authors.forename: M
authors.initials: M
authors.lastname: Leníček
authors.forename: M
authors.initials: M
authors.lastname: Zimolová
authors.forename: L
authors.initials: L
authors.lastname: Vítek
authors.forename: M
authors.initials: M
authors.lastname: Jirsa
authors.forename: J
authors.initials: J
authors.lastname: Pitha
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage; D001647:Bile Acids and Salts / Q000378:metabolism*; D001786:Blood Glucose / Q000378:metabolism*; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage; D002783:Cholestenones / Q000097:blood; D002784:Cholesterol / Q000097:blood; D002790:Cholesterol 7-alpha-Hydroxylase / Q000378:metabolism*; D002792:Cholestyramine Resin / Q000008:administration & dosage; D002940:Circadian Rhythm / Q000502:physiology*; D004789:Enzyme Activation; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005765:Gastrointestinal Agents / Q000008:administration & dosage; D006801:Humans; D007328:Insulin / Q000097:blood*; D008297:Male; D012016:Reference Values; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D001786:Blood Glucose; D002783:Cholestenones; D005230:Fatty Acids, Nonesterified; D005765:Gastrointestinal Agents; D007328:Insulin; D014280:Triglycerides; D002635:Chenodeoxycholic Acid; D002792:Cholestyramine Resin; C002656:7 alpha-hydroxy-4-cholesten-3-one; D002784:Cholesterol; D002790:Cholesterol 7-alpha-Hydroxylase